FDA clears Biosense EP ablation, mapping software

The FDA has cleared Biosense Webster’s CartoXpress software module and the Lasso Nav circular mapping catheter for use with the Carto XP mapping system.

Electrophysiologists can now visualize the Lasso catheter and would be able to utilize the fast anatomical mapping (FAM) feature that, up until now, was only available on the Carto 3 mapping and ablation system, according to the Diamond Bar, Calif.-based company. FAM creates high-resolution maps as an EP moves the catheter throughout the cardiac chamber.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.